Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing admin@sinochem-nanjing.com 3389378665@qq.com
Follow us:

N-Fluorenylmethoxycarbonyl-O-(2-Bromobenzyloxycarbonyl)-L-Tyrosine

    • Product Name N-Fluorenylmethoxycarbonyl-O-(2-Bromobenzyloxycarbonyl)-L-Tyrosine
    • Alias Fmoc-Tyr(2-Br-Z)-OH
    • Einecs 84624-21-3
    • Mininmum Order 1 g
    • Factory Site Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing
    • Price Inquiry admin@sinochem-nanjing.com
    • Manufacturer Sinochem Nanjing Corporation
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    644794

    Product Name N-Fluorenylmethoxycarbonyl-O-(2-Bromobenzyloxycarbonyl)-L-Tyrosine
    Synonyms Fmoc-Tyr(2-Br-Z)-OH
    Molecular Formula C32H24BrNO6
    Cas Number 109425-51-6
    Appearance White to off-white powder
    Purity Typically ≥98%
    Storage Temperature 2-8°C
    Solubility Soluble in DMF, DMSO, and slightly in methanol
    Application Peptide synthesis
    Protecting Groups Fmoc (N-terminal), 2-Br-Z (phenolic hydroxyl)
    Optical Rotation [α]20/D +15 to +25° (c=1, DMF)
    Inchi Key RKSZPCYXLNHHSN-UHFFFAOYSA-N
    Hazard Statements May cause skin and eye irritation

    As an accredited N-Fluorenylmethoxycarbonyl-O-(2-Bromobenzyloxycarbonyl)-L-Tyrosine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing
    Shipping
    Storage
    Application of N-Fluorenylmethoxycarbonyl-O-(2-Bromobenzyloxycarbonyl)-L-Tyrosine

    Applications of N-Fluorenylmethoxycarbonyl-O-(2-Bromobenzyloxycarbonyl)-L-Tyrosine in Industrial Manufacturing

    N-Fluorenylmethoxycarbonyl-O-(2-Bromobenzyloxycarbonyl)-L-Tyrosine serves as a protected amino acid intermediate integral to advanced peptide synthesis and biopharmaceutical manufacturing. By leveraging its dual protecting groups, contract manufacturers and research-driven producers in the life sciences sector achieve precision in multi-step synthesis and process chemistry. Below, we outline industrially confirmed use cases where this specialty amino acid derivative delivers process value and conforms to stringent production requirements.

    1. Peptide Active Pharmaceutical Ingredient (API) Synthesis

    The specialty-protected tyrosine derivative is frequently applied in stepwise solid-phase peptide synthesis (SPPS) for small molecule and peptide-based APIs. Its orthogonal protection enables selective deprotection, minimizing side reactions and reducing purification cycles. Pharmaceutical companies incorporate the material during the assembly of complex linear or cyclic peptides, particularly in sequences sensitive to side-chain modifications or brominated tyrosine analogs required for receptor-binding optimizations in drug candidates.

    Industry compliance standards

    • ICH Q7 Good Manufacturing Practice for Active Pharmaceutical Ingredients
    • US Pharmacopoeia (USP) monographs for peptide APIs
    • European Pharmacopoeia (Ph. Eur.) guidance for synthetic peptides
    • FDA 21 CFR Part 210/211

    Typical usage ratio

    • Used at 1:1 molar equivalence to the intended tyrosine site in the peptide sequence, with potential 5-10% overage to compensate for materials handling and minor yield loss during scale-up.

    Downstream process integration

    • Charged during Fmoc-SPPS chain elongation to install tyrosine sites with selective O-protection; coupled using in situ activation reagents after resin swelling and base washing.

    Final product types

    • Peptide drug substances (APIs)
    • Brominated peptide analogs for oncology and metabolic disorder therapeutics
    • GMP-grade generic and NCE peptide intermediates

    2. Custom Peptide Reagent Manufacturing for Research

    Academic core facilities and specialty peptide suppliers use the protected tyrosine derivative to generate reagents for kinase assays, antibody production, and phosphoproteomics. Bromobenzyl protection on the tyrosine side chain allows for subsequent orthogonal modification or labeling, facilitating site-specific conjugations used in antibody-drug conjugates (ADC) and molecular probe development.

    Industry compliance standards

    • ISO 9001:2015 Quality Management Systems for peptide reagent manufacturing
    • REACH registration and CLP compliance (Europe) for laboratory chemicals
    • GLP (Good Laboratory Practice) for QC of analytical-grade peptides
    • Material Transfer Agreements (institution-specific)

    Typical usage ratio

    • In peptide assembly, dosed stoichiometrically to match sequence requirements, typically 0.5–2 mmol per batch depending on target peptide length and scale of research-order synthesis.

    Downstream process integration

    • Loaded onto resins during early cycle of automated SPPS or manual synthesizer runs; subsequent steps may involve site-specific introduction of probes or enzyme substrates after selective deprotection.

    Final product types

    • Custom peptide libraries for drug screening
    • Synthetic phosphopeptides for signaling pathway studies
    • Peptide bioconjugates for ADC linker development

    3. Diagnostic Peptide Assembly for Immunoassays

    In vitro diagnostics (IVD) manufacturers employ this protected intermediate when assembling synthetic peptides that function as antigens or controls in immunoassay kits. The bromobenzyl group on the tyrosine side chain reduces premature cross-linking or oxidation during high-throughput synthesis, allowing for effective downstream biotinylation or reporter tagging without compromising peptide integrity.

    Industry compliance standards

    • ISO 13485:2016 Medical Devices – Quality management systems for IVD
    • FDA 21 CFR Part 820 Quality System Regulation (QSR)
    • IVD Directive 98/79/EC conformity for diagnostic reagents
    • Clinical and Laboratory Standards Institute (CLSI) protocols

    Typical usage ratio

    • Added to the primary sequence at the exact stoichiometric ratio for each peptide; batch scales range from 0.01–0.5 mol, with slight oversupply (2–5%) during bulk synthesis for kit production lots.

    Downstream process integration

    • Introduced during the protected amino acid coupling phase of SPPS prior to C-terminal cleavage; selective deprotection occurs just prior to post-synthetic peptide modification and formulation.

    Final product types

    • Synthetic peptide antigens
    • Calibrator peptides for ELISA and chemiluminescence assays
    • Peptide-conjugated diagnostic beads

    4. Synthesis of Peptidomimetic Enzyme Inhibitors

    Specialty chemical manufacturers apply this tyrosine intermediate in the assembly of peptidomimetic scaffolds and pseudopeptide drugs. The dual protecting groups allow for iterative synthesis workflows that require selective exposure of functional groups for cyclization, backbone modification, or halogenation. This minimizes byproduct formation and enables manufacturing of enzyme inhibitors targeting kinases, proteases, and GPCRs.

    Industry compliance standards

    • ICH Q11 Development and Manufacture of Drug Substances (Chemical Entities and Biotechnological/Biological Entities)
    • Certified ISO 14001:2015 Environmental Management Systems for chemical production
    • GMP guidelines of China NMPA (for domestic preparations)

    Typical usage ratio

    • Typically introduced at a 1:1 stoichiometric ratio relative to the substituted residue position, with an allowance of 3–8% excess to accommodate waste in purification and multi-step processing.

    Downstream process integration

    • Added during backbone elongation phases in solution or solid-phase synthetic cycles for peptidomimetics; protected group manipulation tailored to allow later functionalization or halogen exchange steps.

    Final product types

    • Macrocyclic peptidomimetic drug candidates
    • Halogenated synthetic enzyme inhibitors
    • Investigational new drug (IND) intermediates

    5. High-Purity Peptide Marker Preparation for Mass Spectrometry Standards

    Producers of analytical standards and reference markers incorporate this protected tyrosine derivative for synthesizing isotopically labeled or structurally defined peptide markers used in quantitative LC-MS and MALDI-MS applications. The brominated protection ensures minimal side-chain oxidation and unintentional modifications during extended solid-phase or solution-phase assembly, supporting the reliability required for trace-level calibration.

    Industry compliance standards

    • ISO/IEC 17025:2017 Accreditation for Testing and Calibration Laboratories
    • USP General Chapter <1224> on Reference Standards
    • ISO Guide 34:2009 for reference material production (now ISO 17034)

    Typical usage ratio

    • Applied at the theoretical yield for each analytical peptide, often 100–120% of theoretical to allow for analytical loss and secondary purification; batch sizes range from milligram to gram levels based on final marker requirements.

    Downstream process integration

    • Charged during targeted peptide construction in SPPS workflows; protecting groups are removed post-assembly in controlled deprotection steps, then the peptide undergoes isotopic labeling or secondary derivatization before QC and lyophilization.

    Final product types

    • Calibrant peptides for mass spectrometry
    • Peptide-based certified reference materials (CRMs)
    • Internal standards for proteomics quantification
    Free Quote

    Competitive N-Fluorenylmethoxycarbonyl-O-(2-Bromobenzyloxycarbonyl)-L-Tyrosine prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.

    We will respond to you as soon as possible.

    Tel: +8615371019725

    Email: admin@sinochem-nanjing.com

    Get Free Quote of Sinochem Nanjing Corporation

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    Introducing N-Fluorenylmethoxycarbonyl-O-(2-Bromobenzyloxycarbonyl)-L-Tyrosine: Advancing Peptide Synthesis With Confidence

    A Closer Look at Fmoc-O(2-BrZ)-L-Tyrosine

    Walk into any modern research lab focused on organic synthesis or peptide development, and you’ll probably see shelves lined with glass bottles labeled in a confusing shorthand of letters, numbers, and molecular tweaks. Among these, N-Fluorenylmethoxycarbonyl-O-(2-Bromobenzyloxycarbonyl)-L-Tyrosine—better known as Fmoc-O(2-BrZ)-L-Tyrosine—plays a special role. This protected amino acid seems esoteric from its name, but for those working in solid-phase peptide synthesis, it's like a trusty wrench: a tool you grab anytime a complex peptide project comes up short.

    Having used many Fmoc-protected amino acids myself, I’ve come to depend on certain derivatives for their reliability under the pressures of peptide assembly. Fmoc-O(2-BrZ)-L-Tyrosine doesn’t just bring the standard protections of the Fmoc group for the N-terminus; the O-(2-bromobenzyloxycarbonyl) capping on the tyrosine side chain pushes things further. The brominated benzyl group offers a layer of selectivity for downstream reactions, especially when traditional protecting groups complicate later functionalization or deprotection steps. That point alone saves time and headaches during multi-step syntheses.

    From Lab Bench to Discovery: Why Protection Matters

    Every chemist carrying out peptide synthesis faces the same headache: making sure each amino acid joins in the right order, with the right side chains protected from unwanted reactions. In my earliest attempts, I watched hours of work go out the window due to incomplete reactions or stubborn side products—usually because a side-chain protecting group wasn’t stable enough, or it wouldn’t come off cleanly when needed.

    Fmoc-O(2-BrZ)-L-Tyrosine addresses that by keeping the hydroxyl group of tyrosine under control with the 2-bromobenzyloxycarbonyl cap. For synthetic routes requiring selective deprotection steps—say, you need to free the phenol after assembling a peptide chain—this group gives much more flexibility than standard benzyl protection. Its sensitivity to mild hydrogenolysis allows for removal without scraping away other vital parts of your nascent peptide. That opens up routes for on-resin functionalization or modification without risking the collapse of more fragile protecting schemes.

    Specifications and Why They Matter to the Working Chemist

    A product like Fmoc-O(2-BrZ)-L-Tyrosine often comes with purity levels above 98 percent, taking away uncertainties in reproducibility. Solid form, typically as a white to off-white crystalline powder, lets it dissolve efficiently in solvents commonly used in peptide synthesis like DMF or DCM. I’ve lost track of how many times a bottle with visible moisture or veiled contaminants has thrown off a coupling reaction, so these quality specs do more than fill a line on a certificate: they actively protect one's workflow.

    The Fmoc group protects the alpha-amino group, ensuring that coupling can proceed on the carboxylic end of a growing peptide chain. The O-(2-bromobenzyloxycarbonyl) attached to the phenolic hydrogen of tyrosine offers a strategic handle for orthogonal protection. Instead of dealing with the classic pitfalls of deprotection—especially when harsh treatments ruin precious intermediates—chemists get a clean, manageable solution. This difference in design isn’t an accident; it responds directly to years of frustration with older, less selective strategies.

    Making Solid-Phase Peptide Synthesis a Smoother Task

    The backbone of many drug discovery programs now runs on solid-phase peptide synthesis. As a chemist, I know firsthand how each step can either build confidence or break momentum. Standard Fmoc-protected tyrosine derivatives cover most basic sequences, but once you step into more complex materials—peptide vaccines, enzyme inhibitors, or probes—side-chain modifications start to trip things up. The O-(2-bromobenzyloxycarbonyl) group brings stability in coupling, holding strong through Fmoc deprotection cycles using piperidine, but it’s still gentle enough to come off without dragging the peptide into chaotic decomposition during mild hydrogenolysis.

    That benefit is felt most during large-scale peptide buildouts. Fewer side reactions, less scrambling for side-chain integrity, and a much easier final purification process. Technologies like microwave-assisted peptide synthesizers can churn out chains of 30, 40, or even more amino acids these days; protected groups that can keep pace and not lag behind become indispensable. Fmoc-O(2-BrZ)-L-Tyrosine stands up to accelerated protocols without demanding hyper-specialized conditions or resorting to reruns when things go awry.

    Distinctive Edge Over Commercial Alternatives

    Plenty of protected tyrosine derivatives line the lab supplier catalogs. Alternatives like Fmoc-Tyr(tBu)-OH or Fmoc-Tyr(Bzl)-OH remain popular, but not all provide the same chemical versatility. tBu, the tert-butyl ether, resists many acid treatments—great for some workflows but too stubborn for others. Benzyl groups, removed by hydrogenation, sometimes stay put or pop off neighboring groups if you’re unlucky. The 2-bromo twist on the benzyl carbamate alters its reactivity just enough: more susceptible to hydrogen cleavage, but robust throughout the rest of the synthesis cycles.

    I've witnessed entire peptide analog projects stall out because a single protecting group proved incompatible with a side reaction needed late in the synthesis. Fmoc-O(2-BrZ)-L-Tyrosine changes the conversation: it can be set aside and addressed only once you’re ready, making late-stage phenol manipulations or post-synthesis labeling strategies more achievable. Selectivity like this means less cross-talk and cleaner results.

    Smoother Peptide Development in Diverse Research Areas

    Researchers in drug design, biomaterial engineering, or biochemical tool development keep looking for new structures and functions in peptides. Tyrosine’s phenolic group is a gateway for attaching fluorescent tags, enzyme-sensitive triggers, or cyclization units. Without reliable, clean deprotection, many of these new directions would stay locked behind synthetic barriers.

    Take peptide drugs aimed at modulating signaling proteins or enzymes—where tyrosine residues serve as a functional hook for further elaboration. Fmoc-O(2-BrZ)-L-Tyrosine’s orthogonal protection simplifies attaching those components at exactly the right time, ensuring site-specificity instead of uncontrolled side reactions. That’s critical for both reproducibility and regulatory compliance in the pharmaceutical sector, which cares as much about the “how” as the “what” of peptide manufacture.

    Improved Process Control and Consistency

    One factor often overlooked by chemists fresh out of school is batch consistency. Variations in purity, moisture content, or particle size can snowball into disastrous yields at even modest scales. Having spent time troubleshooting what at first seemed like mysterious coupling inefficiencies, I learned that the devil really is in the details. Reagent-grade Fmoc-O(2-BrZ)-L-Tyrosine, delivered with tightly controlled specs, narrows the window of risk.

    Labs pursuing Good Manufacturing Practice or other regulated production need every product to meet strict traceability and qualification. Reliable specifications help guard the entire chain, from the benchtop to the regulatory submission. Strong documentation and reproducibility help pharmaceutical scientists sleep better at night, especially when scaling from milligram to multi-kilogram runs.

    Addressing Troubles in Traditional Synthesis

    The sheer investment required to bring a peptide-based drug or diagnostic through testing means lost reactions cost more than just wasted time. Older protection schemes, like simple benzyl or tBu ethers for tyrosine, often left researchers wrestling with partial deprotection, messier HPLC traces, and product loss during purification. Switching to Fmoc-O(2-BrZ)-L-Tyrosine has sidestepped many of these hazards in practice.

    Its performance in stepwise solid-phase synthesis reflects careful adaptation—side reactions drop off, the need for harsh conditions fades, and product isolation comes with fewer surprises. This means less time spent in the fume hood cleaning glassware from sticky, partially deprotected intermediates and more time analyzing actual candidates for efficacy or safety.

    Reducing Environmental and Safety Risks

    Responsible research calls for minimizing both chemical waste and occupational risk. Synthesis routes that lean on milder deprotection protocols avoid the most hazardous reagents and conditions. Fmoc-O(2-BrZ)-L-Tyrosine fits into workflows that favor gentle deprotection by catalytic hydrogenation, staying far away from strong acids or bases that cause spill risks and generate hazardous waste.

    By swapping out harsher chemicals in favor of more selective alternatives, chemists can keep both their exposures and their fume hood burdens down—something I prioritize in every lab where I've trained students or collaborated with environmental health and safety teams.

    Future Promise: Expanding Horizons in Peptide Innovation

    The push toward biologically active peptides, peptidomimetics, and conjugated biomolecules keeps growing every year. With new analytical standards and possibilities like on-resin modification, orthogonally protected amino acids such as Fmoc-O(2-BrZ)-L-Tyrosine stand to become even more central in the development of advanced therapeutics and molecular probes. Chemists are already placing bets on compounds with novel post-synthesis modifications—whether attaching fluorophores, toxins, or linker units—and the need for selective protection has never been greater.

    Fmoc-O(2-BrZ)-L-Tyrosine, with its unique blend of N-terminal and orthogonal phenol protection, enables synthetic access to these more sophisticated constructs. That opens new doors for targeting, tracing, or activating peptides in vivo and in vitro, pushing research projects further and faster than rigid, traditional protection schemes allowed.

    A Chemist's Perspective: Building Reliable Pipelines

    Years of working with peptide synthetic routes have taught me that the best chemistry balances control, adaptability, and simplicity. Fmoc-O(2-BrZ)-L-Tyrosine avoids overcomplicating a process that already demands attention to detail at every step. It lets chemists focus on the science rather than the scavenger hunt of troubleshooting incompatible groups or fussy deprotection conditions.

    Quality of life in the lab improves too. Fewer inconsistent reactions mean less time separating reaction mixtures by hand, and more time running productive syntheses. In teams where multiple people share workflows, standardizing on reagents with proven performance streamlines handoffs and lowers training needs. Adopting this tyrosine derivative absorbs uncertainty and supports seamless collaboration.

    Navigating Supply Chain and Product Availability

    As research budgets tighten and timelines accelerate, supply reliability rises in importance. In my own experience, consistent access to high-quality Fmoc-O(2-BrZ)-L-Tyrosine speeds up project starts and sidesteps last-minute scrambles. Labs not only safeguard their own timelines but also ensure external collaborations keep moving when everyone uses comparable-grade materials.

    Global scale-up or technology transfer to production partners requires predictability. Standardized packaging formats, stable shelf lives, and reliable analytical support keep the focus on advancing science rather than chasing overlooked quality failures. Experienced suppliers working under ISO or similar compliance schemes provide that confidence as a matter of routine, freeing scientific teams to think long-term.

    Practical Strategies for Getting the Most Out of Fmoc-O(2-BrZ)-L-Tyrosine

    To fully capitalize on the potential of this protected tyrosine, integrating strong analytical controls at each step pays off. Use HPLC and mass spectrometry to confirm loading efficiencies and integrity after coupling cycles. Keep reaction conditions within recommended solvent, temperature, and pH ranges to prevent premature group loss or side reactions. Store materials in dry, cool, and dark conditions to extend shelf life and minimize degradation.

    Combining these habits with routine calibration and procedural checks cements reproducibility. Whether working in an academic, biotech, or pharmaceutical setting, systematic adoption of robust Fmoc-protected amino acids improves yield and lowers troubleshooting time—critical for both seasoned synthetic chemists and newer team members learning the ropes.

    Moving Toward Greener, More Accountable Chemistry

    Contemporary chemical science centers accountability for both results and environmental impact. Reagents that allow for atom economy, less harsh chemistry, and minimal waste strengthen the case for responsible discovery. Fmoc-O(2-BrZ)-L-Tyrosine fits into a toolkit aimed at greener chemistry solutions by limiting the use of aggressive reagents, easing purification demands, and supporting safer deprotection sequences. Many institutions set goals for reduced solvent and toxic reagent use, and reagents like this smooth the transition.

    In my view, every decision to streamline workflows with reliable, greener reagents represents a step forward in building a lab culture that values both competitive progress and environmental stewardship. The ease of handling and reduced downstream processing enabled by orthogonal protecting groups directly supports these efforts, reinforcing the connection between rigorous science and future-oriented responsibility.

    Conclusion: Trust and Flexibility With Every Synthesis

    Fmoc-O(2-BrZ)-L-Tyrosine encapsulates decades of progress in the careful design of building blocks for peptide chemistry. It earns that place in the lab not through marketing claims, but through practical, proven performance. For those of us who keep striving for better peptides—tougher, more versatile, and finely tuned to their biological targets—the right kind of protection is everything. This tool helps cut through complexity, make better science, and keep discovery moving forward.